-
1
An Anaplastic Lymphoma Kinase-positive Inflammatory Myofibroblastic Tumor with Rapidly Acquired Resistance to First-line Anaplastic Lymphoma Kinase Inhibitor: A Case and Literature...
Published 2024-01-01Subjects: “…anaplastic lymphoma kinase inhibitor…”
Get full text
Article -
2
Risk Stratification and Adjuvant Chemotherapy for High‐Risk Stage IA Lung Adenocarcinoma: The Unmet Needs
Published 2025-01-01Subjects: Get full text
Article -
3
An open-label study to determine the maximum tolerated dose of oral ESK-440 administered as a single agent in patients with advanced or metastatic solid tumors
Published 2025-03-01Subjects: “…Anaplastic lymphoma kinase (ALK)…”
Get full text
Article